Efg Asset Management (North America) Corp. Insmed Inc Transaction History

Efg Asset Management (North America) Corp.

$724 Million
Q3 2025

A detailed history of Efg Asset Management (North America) Corp. transactions in Insmed Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 14,973 shares of INSM stock, worth $2.89 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

14,973

Previous 63,529 76.43%

Holding current value

$2.89 Million

Previous $6.39 Million 66.28%

% of portfolio

0.3%

Previous 0.95%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$96.14 - $147.2 $4.67 Million - $7.15 Million	-48,556 Reduced 76.43%	14,973 $2.16 Million
Q2 2025 Aug 05, 2025	SELL	$64.81 - $105.9 $1.99 Million - $3.25 Million	-30,696 Reduced 32.58%	63,529 $6.39 Million
Q1 2025 May 14, 2025	SELL	$65.25 - $83.83 $874,350 - $1.12 Million	-13,400 Reduced 12.45%	94,225 $7.19 Million
Q4 2024 Feb 11, 2025	BUY	$66.29 - $76.63 $3.76 Million - $4.35 Million	56,758 Added 111.58%	107,625 $7.43 Million
Q3 2024 Nov 12, 2024	SELL	$62.0 - $79.01 $187,922 - $239,479	-3,031 Reduced 5.62%	50,867 $3.71 Million

Q2 2024 Jul 25, 2024	SELL	$22.0 - $69.71 $410,080 - $1.3 Million	-18,640 Reduced 25.7%	53,898 $3.61 Million
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $329,576 - $383,651	12,814 Added 21.46%	72,538 $1.97 Million
Q4 2023 Feb 08, 2024	BUY	$23.42 - $31.74 $164,666 - $223,163	7,031 Added 13.34%	59,724 $1.85 Million
Q3 2023 Nov 02, 2023	SELL	$19.86 - $26.93 $99,915 - $135,484	-5,031 Reduced 8.72%	52,693 $1.33 Million
Q2 2023 Jul 28, 2023	SELL	$16.44 - $21.1 $56,159 - $72,077	-3,416 Reduced 5.59%	57,724 $1.22 Million
Q1 2023 Apr 27, 2023	SELL	$16.26 - $21.73 $55,657 - $74,381	-3,423 Reduced 5.3%	61,140 $1.04 Million
Q4 2022 Feb 03, 2023	BUY	$16.98 - $23.15 $277,062 - $377,738	16,317 Added 33.82%	64,563 $1.29 Million
Q3 2022 Oct 28, 2022	SELL	$20.88 - $28.21 $970,585 - $1.31 Million	-46,484 Reduced 49.07%	48,246 $1.04 Million
Q2 2022 Aug 04, 2022	SELL	$17.07 - $25.71 $138,744 - $208,970	-8,128 Reduced 7.9%	94,730 $1.87 Million
Q1 2022 Apr 26, 2022	SELL	$20.42 - $28.13 $18,745 - $25,823	-918 Reduced 0.88%	102,858 $2.42 Million
Q4 2021 Feb 18, 2022	BUY	$25.89 - $33.45 $2.69 Million - $3.47 Million	103,776 New	103,776 $2.83 Million

Others Institutions Holding INSM

# of Institutions

643

Shares Held

208M

Call Options Held

3.83M

Put Options Held

4.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $26.2B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account

Efg Asset Management (North America) Corp. Insmed Inc Transaction History